Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lung Capacity01:47

Lung Capacity

56.3K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.3K
Tumor Progression02:07

Tumor Progression

7.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
Second Order systems II01:18

Second Order systems II

408
In an underdamped second-order system, where the damping ratio ζ is between 0 and 1, a unit-step input results in a transfer function that, when transformed using the inverse Laplace method, reveals the output response. The output exhibits a damped sinusoidal oscillation, and the difference between the input and output is termed the error signal. This error signal also demonstrates damped oscillatory behavior. Eventually, as the system reaches a steady state, the error diminishes to zero.
408
First Order Systems01:21

First Order Systems

430
First-order systems, such as RC circuits, are foundational in understanding dynamic systems due to their straightforward input-output relationship. Analyzing their responses to different input functions under zero initial conditions reveals significant insights into system behavior.
When a first-order system is subjected to a unit-step input, its response is characterized by its transfer function. By applying the Laplace transform of the unit-step input to the transfer function, expanding the...
430
Second Order systems I01:20

Second Order systems I

598
A servo system exemplifies a second-order system, featuring a proportional controller and load elements that ensure the output position aligns with the input position. The relationship between these components is described by a second-order differential equation. Applying the Laplace transform under zero initial conditions yields the transfer function, showing how inputs are converted to outputs in the system.
By reinterpreting the system, one can derive the closed-loop transfer function, which...
598
Thermodynamic Systems01:06

Thermodynamic Systems

8.1K
A thermodynamic system is a set of objects whose thermodynamic properties are of interest. The system is considered to be embedded in its surroundings or the environment. The system and its environment can exchange heat and do work on each other through a boundary that separates them. However, the immediate surroundings of the system interact with it directly and therefore have a much stronger influence on its behavior and properties.
Consider an example of  tea boiling in a kettle. The...
8.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autoantibody associations in patients with early diffuse cutaneous systemic sclerosis: the prospective registry of early systemic sclerosis.

Seminars in arthritis and rheumatism·2026
Same author

Palliative care in systemic sclerosis: incorporating advance care planning into longitudinal care.

Journal of scleroderma and related disorders·2026
Same author

Rheumatoid arthritis-associated interstitial lung disease: screening, diagnosis, and treatment-an expert group consensus statement.

The Lancet. Respiratory medicine·2026
Same author

Discordance Between Patient and Physician Global Assessments in Early Systemic Sclerosis.

Arthritis care & research·2026
Same author

Deep learning-derived quantitative interstitial abnormalities in early rheumatoid arthritis and healthy controls: A multicenter, prospective cross-sectional study.

medRxiv : the preprint server for health sciences·2026
Same author

A CD57+CD8+ T cell subset links T cell cytotoxicity to fibrotic lung disease in systemic sclerosis.

The Journal of clinical investigation·2026

Related Experiment Video

Updated: Feb 5, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.9K

Recent progress in systemic sclerosis-interstitial lung disease.

Flavia V Castelino1, Paul F Dellaripa2

  • 1Division of Rheumatology, Massachusetts General Hospital.

Current Opinion in Rheumatology
|September 21, 2018
PubMed
Summary
This summary is machine-generated.

Systemic sclerosis patients with interstitial lung disease (ILD) face challenges in predicting progression. Emerging insights and risk models aim to identify high-risk individuals for novel therapies targeting lung fibrosis.

More Related Videos

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

11.6K
Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs
05:11

Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs

Published on: May 10, 2024

1.9K

Related Experiment Videos

Last Updated: Feb 5, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

20.9K
Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis
08:11

Measuring Progressive Neurological Disability in a Mouse Model of Multiple Sclerosis

Published on: November 14, 2016

11.6K
Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs
05:11

Author Spotlight: Establishing a Murine Non-Small Cell Lung Cancer Model for Developing Nanoformulations of Anticancer Drugs

Published on: May 10, 2024

1.9K

Area of Science:

  • Autoimmune diseases
  • Pulmonary fibrosis
  • Rheumatology

Background:

  • Systemic sclerosis is an autoimmune disorder where interstitial lung disease (ILD) is a primary cause of mortality.
  • Understanding the mechanisms of fibrosis and autoimmunity in lung tissue is crucial for scleroderma treatment.
  • This review focuses on recent advancements in scleroderma-related ILD.

Purpose of the Study:

  • To highlight emerging insights into scleroderma-related interstitial lung disease (ILD).
  • To discuss current and upcoming clinical trials for treating ILD in systemic sclerosis.
  • To address the challenges in identifying patients at risk for ILD progression.

Main Methods:

  • Review of current literature on systemic sclerosis and ILD.
  • Analysis of risk assessment models for ILD progression.
  • Discussion of ongoing and recent clinical trials for scleroderma ILD.

Main Results:

  • Challenges remain in identifying patients with progressive ILD in systemic sclerosis.
  • Risk assessment models incorporating radiographic and physiologic data are being developed.
  • Novel therapeutic strategies are under investigation for managing lung fibrosis in scleroderma.

Conclusions:

  • Advancements in risk stratification may enable earlier identification of high-risk patients.
  • Novel therapies hold promise for limiting the progression of lung disease in systemic sclerosis.
  • A paradigm shift in managing scleroderma-related ILD is anticipated with ongoing research.